Phase IIa Clinical Trial of Tamibarotene in Patients With Autosomal Dominant Polycystic Kidney Disease
Clinical trial of tamibarotene in patients with Autosomal Dominant Polycystic Kidney Disease
100 Clinical Results associated with Rege Nephro Co. Ltd.
0 Patents (Medical) associated with Rege Nephro Co. Ltd.
100 Deals associated with Rege Nephro Co. Ltd.
100 Translational Medicine associated with Rege Nephro Co. Ltd.